Pulmonary scintigraphy Inhalation

Inhalation pulmonary scintiography (IPSG) is a diagnostic method used to assess lung function and identify diseases of the respiratory system. It involves injecting radioactive tracers into the lungs, which are then detected in images taken with a gamma camera.

IPSG is one of the most accurate methods for diagnosing lung diseases. It allows you to detect the presence of inflammatory processes, tumors, infections and other diseases that can affect lung function.

The IPSG procedure is performed as follows: the patient is injected with a radioactive tracer into the lungs through a tube that is placed in the airway. The patient then breathes into a chamber, which records changes in the radioactivity of the tracer. The data obtained is processed on a computer, which makes it possible to obtain an image of the lungs.

Advantages of IPSG include high accuracy, the ability to detect early stages of disease, and the ability to conduct the study in patients with limited mobility or in serious condition.

However, like any other diagnostic method, IPSG has its limitations. For example, radiotracers can expose the patient to radiation, which can be hazardous to health. In addition, the procedure can be expensive and requires special equipment and trained personnel.

In general, inhalation pulmonary scintigraphy is an important method for diagnosing lung diseases, which makes it possible to detect diseases in the early stages and carry out effective treatment.

**Pulmonoscintigraphy** is a technique that allows you to visualize the functional state of the bronchial tree, trachea and pulmonary parenchyma. The method is used to diagnose inflammatory, dystrophic, and tumor diseases of the respiratory system. The source of ionizing radiation is a radiopharmaceutical (RP), which is administered intravenously or by inhalation. The most commonly used iodine compounds are Tc-99m pertechnetate or technetium iodotechnetate Tc-94m. Scanning is carried out within 24-36 hours